131 related articles for article (PubMed ID: 2253054)
1. Establishment of two new multi-drug resistant variants of the human tumor line Hep-2.
Redmond A; Law E; Gilvarry U; Clynes M
Cell Biol Toxicol; 1990 Jul; 6(3):293-302. PubMed ID: 2253054
[TBL] [Abstract][Full Text] [Related]
2. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
Parekh H; Simpkins H
Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
[TBL] [Abstract][Full Text] [Related]
3. Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype.
Schisselbauer JC; Crescimanno M; D'Alessandro N; Clapper M; Toulmond S; Tapiero H; Tew KD
Cancer Commun; 1989; 1(2):133-9. PubMed ID: 2639724
[TBL] [Abstract][Full Text] [Related]
4. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
Moy BC; Petzold GL; Badiner GJ; Kelly RC; Aristoff PA; Adams EG; Li LH; Bhuyan BK
Cancer Res; 1990 Apr; 50(8):2485-92. PubMed ID: 2317831
[TBL] [Abstract][Full Text] [Related]
5. Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line.
Zalcberg JR; Hu XF; Wall DM; Mirski S; Cole S; Nadalin G; De Luise M; Parkin JD; Vrazas V; Campbell L
Int J Cancer; 1994 May; 57(4):522-8. PubMed ID: 7514153
[TBL] [Abstract][Full Text] [Related]
6. Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells.
Wolverton JS; Danks MK; Schmidt CA; Beck WT
Cancer Res; 1989 May; 49(9):2422-6. PubMed ID: 2539902
[TBL] [Abstract][Full Text] [Related]
7. Components of intrinsic drug resistance in the rat hepatoma.
Ellis AL; Munger CE; Bunch RT; Woods KE; Randolph JK; Boise L; Swerdlow PS; Zwelling LA; Hinds M; Yanovich S
Biochem Pharmacol; 1992 Jan; 43(2):331-42. PubMed ID: 1310853
[TBL] [Abstract][Full Text] [Related]
8. Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.
Clynes M; Redmond A; Moran E; Gilvarry U
Cytotechnology; 1992; 10(1):75-89. PubMed ID: 1369413
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
10. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
11. Establishment of tumor cell lines from a patient with head and neck cancer and their different sensitivities to anti-cancer agents.
Komiyama S; Matsui K; Kudoh S; Nogae I; Kuratomi Y; Saburi Y; Asoh K; Kohno K; Kuwano M
Cancer; 1989 Feb; 63(4):675-81. PubMed ID: 2914273
[TBL] [Abstract][Full Text] [Related]
12. Selection of tumor cell variants for resistance to tumor necrosis factor also induces a form of pleiotropic drug resistance.
Wright SC; Tam AW; Kumar P
Cancer Immunol Immunother; 1992; 34(6):399-406. PubMed ID: 1563018
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of drug-sensitivity and cross-resistance profiles of cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia.
Seneviratne C; Goldenberg GJ
Cancer Commun; 1989; 1(1):21-7. PubMed ID: 2640153
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line.
Bénard J; Da Silva J; Teyssier JR; Riou G
Int J Cancer; 1989 Mar; 43(3):471-7. PubMed ID: 2925277
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance to the lipid-soluble antifolate trimetrexate in human carcinoma cells with the multidrug-resistant phenotype.
Assaraf YG; Molina A; Schimke RT
J Natl Cancer Inst; 1989 Feb; 81(4):290-4. PubMed ID: 2521520
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
Politi PM; Arnold ST; Felsted RL; Sinha BK
Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
[TBL] [Abstract][Full Text] [Related]
20. Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin.
Tomida A; Naito M; Tsuruo T
Jpn J Cancer Res; 1995 Feb; 86(2):224-32. PubMed ID: 7730148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
